| Literature DB >> 17010676 |
P Madeddu1, C Emanueli, F Spillmann, M Meloni, N Bouby, C Richer, F Alhenc-Gelas, V Van Weel, D Eefting, P H A Quax, Y Hu, Q Xu, A L Hemdahl, J van Golde, M Huijberts, Q de Lussanet, H Struijker Boudier, T Couffinhal, C Duplaa, S Chimenti, L Staszewsky, R Latini, V Baumans, B I Levy.
Abstract
Ischemic disease represents the new epidemic worldwide. Animal models of ischemic disease are useful because they can help us to understand the underlying pathogenetic mechanisms and develop new therapies. The present review article summarizes the results of a consensus conference on the status and future development of experimentation in the field of cardiovascular medicine using murine models of peripheral and myocardial ischemia. The starting point was to recognize the limits of the approach, which mainly derive from species- and disease-related differences in cardiovascular physiology. For instance, the mouse heart beats at a rate 10 times faster than the human heart. Furthermore, healing processes are more rapid in animals, as they rely on mechanisms that may have lost relevance in man. The main objective of the authors was to propose general guidelines, diagnostic end points and relevance to clinical problems.Entities:
Mesh：
Year: 2006 PMID： 17010676 DOI： 10.1016/j.vph.2006.08.008
Source DB: PubMed Journal: Vascul Pharmacol ISSN： 1537-1891 Impact factor: 5.773